Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice

Toxicology and Applied Pharmacology

Volumn 226, Issue 2, 2008, Pages 128-139

  Arteel, Gavin E ^a,b   Guo, Luping ^a   Schlierf, Thomas ^c   Beier, Juliane I ^c   Kaiser, J Phillip ^a   Chen, Theresa S ^a   Liu, Marsha ^a   Conklin, Daniel J ^a   Miller, Heather L ^a   von Montfort, Claudia ^a   States, J Christopher ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

2 hit model; Apoptosis; Hepatotoxicity; LPS; Mus muscalis; Proliferation; Sodium arsenite

Indexed keywords

ARSENIC; ARSENITE SODIUM; CYCLINE; DRINKING WATER; GLUTATHIONE; LIPOPOLYSACCHARIDE; LIVER ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DEATH; CONTROLLED STUDY; HISTOLOGY; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER TOXICITY; LIVER WEIGHT; MALE; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; APOPTOSIS; ARSENITES; BODY WEIGHT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HEPATITIS, TOXIC; HEPATOCYTES; LIPID METABOLISM; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; SODIUM COMPOUNDS;

ANIMALIA; MUS;

EID: 37349101243     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.08.020     Document Type: Article

References (45)

1. Arteel G.E., Thurman R.G., Yates J.A., and Raleigh J.A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer 72 (1995) 889-895
2. Arteel G., Marsano L., Mendez C., Bentley F., and McClain C.J. Advances in alcoholic liver disease. Best. Pract. Res. Clin. Gastroenterol. 17 (2003) 625-647
3. Bergheim I., Guo L., Davis M.A., Lambert J.C., Beier J.I., Duveau I., Luyendyk J.P., Roth R.A., and Arteel G.E. Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 130 (2006) 2099-2112
4. Caldon C.E., Daly R.J., Sutherland R.L., and Musgrove E.A. Cell cycle control in breast cancer cells. J. Cell. Biochem. 97 (2006) 261-274
5. Chen T.S., Richie J.P., and Lang C.A. Life span profiles of glutathione and acetaminophen detoxification. Drug Metab. Dispos. 18 (1990) 882-887
6. Chen H., Li S., Liu J., Diwan B.A., Barrett J.C., and Waalkes M.P. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25 (2004) 1779-1786
7. Das S., Santra A., Lahiri S., and Guha Mazumder D.N. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol. Appl. Pharmacol. 204 (2005) 18-26
8. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
9. Engel R.R., and Smith A.H. Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch. Environ. Health 49 (1994) 418-427
10. Fortin L.J., and Genest J. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin. Biochem. 28 (1995) 155-162
11. Frost F.J., Muller T., Petersen H.V., Thomson B., and Tollestrup K. Identifying US populations for the study of health effects related to drinking water arsenic. J. Expo. Anal. Environ. Epidemiol. 13 (2003) 231-239
12. Golding M., Sarraf C.E., Lalani E.N., Anilkumar T.V., Edwards R.J., Nagy P., Thorgeirsson S.S., and Alison M.R. Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatology 22 (1995) 1243-1253
13. Gujral J.S., Liu J., Farhood A., Hinson J.A., and Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am. J. Physiol.: Gasterointest. Liver Physiol. 286 (2004) G499-G507
14. Guo L., Richardson K.S., Tucker L.M., Doll M.A., Hein D.W., and Arteel G.E. Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 40 (2004) 583-589
15. Hall M., Chen Y., Ahsan H., Slavkovich V., van Geen A., Parvez F., and Graziano J. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology 225 (2006) 225-233
16. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172 (2001) 249-261
17. Koteish A., Yang S., Lin H., Huang X., and Diehl A.M. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J. Biol. Chem. 277 (2002) 13037-13044
18. Li Z., and Diehl A.M. Innate immunity in the liver. Curr. Opin. Gastroenterology 19 (2003) 565-571
19. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 (2006) S31-S44
20. Mazumder D.N. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol. Appl. Pharmacol. 206 (2005) 169-175
21. McCabe Jr. M.J., Singh K.P., Reddy S.A., Chelladurai B., Pounds J.G., Reiners Jr. J.J., and States J.C. Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase. J. Pharmacol. Exp. Ther. 295 (2000) 724-733
22. McCollum G., Keng P.C., States J.C., and McCabe Jr. M.J. Arsenite delays progression through each cell cycle phase and induces apoptosis following G2/M arrest in U937 myeloid leukemia cells. J. Pharmacol. Exp. Ther. 313 (2005) 877-887
23. McKim S.E., Konno A., Gabele E., Uesugi T., Froh M., Sies H., Thurman R.G., and Arteel G.E. Cocoa extract protects against early alcohol-induced liver injury in the rat. Arch. Biochem. Biophys. 406 (2002) 40-46
24. McNeely S.C., Xu X., Taylor B.F., Zacharias W., McCabe Jr. M.J., and States J.C. Exit from arsenite-induced mitotic arrest is p53 dependent. Environ. Health Perspect. 114 (2006) 1401-1406
25. Merali S., Vargas D., Franklin M., and Clarkson A.B. S-adenosylmethionine and Pneumocystis carinii. J. Biol. Chem. 275 (2000) 14958-14963
26. National Research Council. Arsenic in Drinking Water (1999), National academy press, Washington, DC
27. National Research Council. Arsenic in Drinking Water: 2001 Update (2001), National Academy Press, Washington, DC
28. Patrick L. Toxic metals and antioxidants: part II. The role of antioxidants in arsenic and cadmium toxicity. Altern. Med. Rev. 8 (2003) 106-128
29. Richie J.P., and Lang C.A. The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal. Biochem. 163 (1987) 9-15
30. Santra A., Das G.J., De B.K., Roy B., and Guha Mazumder D.N. Hepatic manifestations in chronic arsenic toxicity. Indian J. Gastroenterol. 18 (1999) 152-155
31. Santra A., Maiti A., Das S., Lahiri S., Charkaborty S.K., and Mazumder D.N. Hepatic damage caused by chronic arsenic toxicity in experimental animals. J. Toxicol. Clin. Toxicol. 38 (2000) 395-405
32. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 33 (2001) 738-750
33. Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.M., Hertz-Picciotto I., Duggan H.M., Wood R., Kosnett M.J., and Smith M.T. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97 (1992) 259-267
34. Solga S.F., and Diehl A.M. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J. Hepatol. 38 (2003) 681-687
35. Straub A.C., Stolz D.B., Ross M.A., Hernandez-Zavala A., Soucy N.V., Klei L.R., and Barchowsky A. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology 45 (2007) 205-212
36. Suzuki T., and Tsukamoto I. Arsenite induces apoptosis in hepatocytes through an enhancement of the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase caused by partial hepatectomy. Toxicol. Lett. 165 (2006) 257-264
37. Taylor B.F., McNeely S.C., Miller H.L., Lehmann G.M., McCabe Jr. M.J., and States J.C. p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. J. Pharmacol. Exp. Ther. 318 (2006) 142-151
38. Torbenson M., Yang S.Q., Liu H.Z., Huang J., Gage W., and Diehl A.M. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am. J. Pathol. 161 (2002) 155-161
39. Trautwein C., Will M., Kubicka S., Rakemann T., Flemming P., and Manns M.P. 2-Acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression. Oncogene 18 (1999) 6443-6453
40. van Goor H., Gerrits P.O., and Grond J. The application of lipid-soluble stains in plastic-embedded sections. Histochemistry 85 (1986) 251-253
41. Waalkes M.P., Liu J., Chen H., Xie Y., Achanzar W.E., Zhou Y.S., Cheng M.L., and Diwan B.A. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96 (2004) 466-474
42. Waalkes M.P., Liu J., Ward J.M., and Diwan B.A. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol. Appl. Pharmacol. 215 (2006) 295-305
43. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2557-2562
44. Yang S.Q., Lin H.Z., Mandal A.K., Huang J., and Diehl A.M. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 94 (2001) 694-706
45. Yang S., Koteish A., Lin H., Huang J., Roskams T., Dawson V., and Diehl A.M. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology 39 (2004) 403-411